These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 2568246
1. Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer. Savarino V, Mela GS, Zentilin P, Bonifacino G, Moretti M, Valle F, Celle G. Dig Dis Sci; 1989 Jul; 34(7):1043-6. PubMed ID: 2568246 [Abstract] [Full Text] [Related]
2. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording. Savarino V, Mela GS, Zentilin P, Scalabrini P, Bonifacino G, Gambaro P, Celle G. Digestion; 1989 Jul; 42(1):1-6. PubMed ID: 2568299 [Abstract] [Full Text] [Related]
3. Overnight comparable anacidity by standard large and half-single bedtime doses of H2 antagonists in duodenal ulcer patients: a clinical pharmacological study. Savarino V, Mela GS, Scalabrini P, Sumberaz A, Fera G, Zentilin P, Celle G. Am J Gastroenterol; 1988 Sep; 83(9):917-22. PubMed ID: 2901220 [Abstract] [Full Text] [Related]
4. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs. Savarino V. Ital J Gastroenterol; 1990 Sep; 22 Suppl 2():20-3. PubMed ID: 1983412 [Abstract] [Full Text] [Related]
5. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients? Fiorucci S, Clausi GG, Farinelli M, Santucci L, Farroni F, Pelli MA, Morelli A. Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218 [Abstract] [Full Text] [Related]
6. The 24-hour acid suppression profile of nizatidine. Dammann HG, Gottlieb WR, Walter TA, Müller P, Simon B, Keohane P. Scand J Gastroenterol Suppl; 1987 Dec; 136():56-60. PubMed ID: 2892256 [Abstract] [Full Text] [Related]
7. A double-blind randomized study comparing different dose regimens of H2-receptor antagonists on 24-hour gastric secretion in normal subjects and duodenal ulcer patients. de Gara CJ, Burget DW, Silletti C, Hunt RH. Am J Gastroenterol; 1987 Jan; 82(1):36-41. PubMed ID: 3099564 [Abstract] [Full Text] [Related]
8. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring. Savarino V, Picciotto A, Magnolia MR, Scalabrini P, Mela GS, Celle G. J Clin Pharmacol; 1987 Oct; 27(10):790-3. PubMed ID: 2892864 [Abstract] [Full Text] [Related]
9. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Jones DB, Howden CW, Burget DW, Kerr GD, Hunt RH. Gut; 1987 Sep; 28(9):1120-7. PubMed ID: 2890561 [Abstract] [Full Text] [Related]
10. Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer. Gledhill T, Howard OM, Buck M, Paul A, Hunt RH. Gut; 1983 Oct; 24(10):904-8. PubMed ID: 6311692 [Abstract] [Full Text] [Related]
11. Twenty-four-hour control of gastric acidity by twice-daily doses of placebo, nizatidine 150 mg, nizatidine 300 mg, and ranitidine 300 mg. Savarino V, Mela GS, Zentilin P, Cutela P, Mele R, Celle G. J Clin Pharmacol; 1993 Jan; 33(1):70-4. PubMed ID: 8429117 [Abstract] [Full Text] [Related]
12. Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine. Dammann HG, Gottlieb WR, Walter TA, Dreyer M, Müller P, Simon B, Keohane P. Hepatogastroenterology; 1986 Oct; 33(5):217-20. PubMed ID: 2879782 [Abstract] [Full Text] [Related]
13. Single morning and nightly doses of ranitidine 300 mg: an appraisal of their antisecretory effects by continuous pH monitoring. Savarino V, Mela GS, Zentilin P, Sumberaz A, Cutela P, Celle G. Digestion; 1991 Oct; 48(3):141-8. PubMed ID: 1916034 [Abstract] [Full Text] [Related]
14. [Inhibition of 24-hour acidity by nizatidine]. Dammann HG, Dreyer M, Gottlieb WR, Wolf N, Müller P, Simon B. Fortschr Med; 1989 May 10; 107(14):321-4. PubMed ID: 2568971 [Abstract] [Full Text] [Related]
15. Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring. Celle G, Savarino V, Mela GS, Scalabrini P, Sumberaz A, Fera G, Zentilin P. Scand J Gastroenterol; 1988 May 10; 23(4):385-90. PubMed ID: 2898167 [Abstract] [Full Text] [Related]
16. Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer. Walt RP, Male PJ, Rawlings J, Hunt RH, Milton-Thompson GJ, Misiewicz JJ. Gut; 1981 Jan 10; 22(1):49-54. PubMed ID: 6109686 [Abstract] [Full Text] [Related]
17. Treatment of duodenal ulceration in the United States. Dyck WP, Cloud ML, Offen WW, Matsumoto C, Chernish SM. Scand J Gastroenterol Suppl; 1987 Jan 10; 136():47-55. PubMed ID: 2892255 [Abstract] [Full Text] [Related]
18. A multicenter, randomized, double-blind study comparing famotidine with ranitidine in the treatment of active duodenal ulcer disease. McCullough AJ. Am J Med; 1986 Oct 24; 81(4B):17-24. PubMed ID: 2877570 [Abstract] [Full Text] [Related]
19. A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine. Savarino V, Mela GS, Scalabrini P, Fera G, Zentilin P, Sumberaz A, Celle G. Eur J Clin Pharmacol; 1988 Oct 24; 35(2):203-7. PubMed ID: 3191940 [Abstract] [Full Text] [Related]
20. Twenty-four-hour intragastric acidity following early evening or bedtime administration of roxatidine in duodenal ulcer patients. Lazzaroni M, Sangaletti O, Bargiggia S, Bensi G, Canali A, Bianchi Porro G. Aliment Pharmacol Ther; 1996 Apr 24; 10(2):187-91. PubMed ID: 8730248 [Abstract] [Full Text] [Related] Page: [Next] [New Search]